14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 72 days ( 15.10 % )
Last Price $0.85 0 %
High/ Low $0.85 - $0.85 0%
Chg 7 Days N/A $0.85 $0.85
Chg 30 Days 3.54 % $0.82 $0.85
Chg 12 mos -69.35 % $2.77 $0.85
Trend - 3 mos -22.54 % Width: 67.66 %
Trend - 12 mos -55.51 % Width: 5,378.60 %
Pred. range - 3 mos $0.425 - $0.713 -49.94 % - -16.07 %
Pred. range - 12 mos N/A - $0.616 -100.00 % - -27.42 %
Short MA avg 3 mos Buy Sep 27, 2022 - 29 days
Long MA avg 3 mos Buy Oct 12, 2022 - 18 days
Short/Long MA avg 3 mos Buy Oct 13, 2022 - 17 days
Short MA avg 12 mos Buy Sep 28, 2022 - 28 days
Long MA avg 12 mos Sell Apr 11, 2022 - 145 days
Short/Long MA avg 12 mos Sell Apr 25, 2022 - 136 days
Pivot Short Sell Nov 03, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Pluristem Therapeutics

Pluristem Therapeutics Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recove... PSTI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT